Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae

Journal of Infection in Developing Countries

Volumn 8, Issue 2, 2014, Pages 154-159

  Daoud, Ziad ^a   Salem Sokhn, Elie ^b   Azar, Eid ^a   Masri, Khalil ^c   Doron, Shira ^d  

^a UNIVERSITY OF BALAMAND   (Lebanon)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c Centre Hospitalier du Nord   (Lebanon)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

Ciprofloxacin; ESBL; Escherichia coli; Klebsiella pneumoniae; Mutant prevention concentration

Indexed keywords

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MUTATION; URINARY TRACT INFECTIONS;

EID: 84893967370     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3164     Document Type: Article

References (21)

1. Webber M, Piddock LJ (2001) Quinolone resistance in Escherichia coli. Vet Res 32: 275-284.
2. Sorlózano A, Gutiérrez J, de Dios Luna J, Oteo J, Liébana J, Soto MJ, Piédrola G (2007) High presence of extended-spectrum beta-lactamases and resistance to quinolones in clinical isolates of Escherichia coli. Microbiol Res 162: 347-354.
3. Pitout JDD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing Extended Spectrum Beta Lactamases (ESBLs) in the community. J Antimicrob Chemoth 56: 52-59.
4. Tran JH, Jacoby GA (2002) Mechanism of plasmidmediated quinolone resistance. Proc Natl Acad Sci 99: 5638-5642
5. Cavaco LM, Hasman H, Xia S, Aarestrup FM (2009) qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother. 53: 603-608.
6. Jacoby G, Cattoir V, Hooper D, Martinez-Martinez L, Nordmann P, Pascual A, Poirel L, Wang M (2008) Qnr Gene nomenclature. Antimicrob Agents Chemother. 52: 2297-2299
7. Robicsek A, Jacoby GA, Hooper DC (2006) The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6: 629-640.
8. Zhao X, and Drlica K (2001) Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolones studies. Clin Infect Dis 33: S147-S56.
9. Dong Y, Zhao X, Domagala J, Drlica K (1999) Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Saphylococcus aureus. Antimicrob Agents Chemother. 43: 1756-1758.
10. Kanj SS, Corkill JE, Kanafani ZA, Araj GF, Hart CA, Jaafar R, Matar GM (2008) Molecular characterisation of Extended Spectrum Beta Lactamase-producing Escherichia coli and Klebsiella spp. isolates at a tertiary-care center in Lebanon. Clin Microbiol Infect 14: 501-504.
11. Daoud Z, Moubareck C, Hakime N, Doucet-Populaire F (2006) Extended Spectrum Beta Lactamase producing Enterobacteriaceae in Lebanese ICU patients: epidemiology and patterns of resistance. J Gen Appl Microbio 52: 169-178
12. Moubareck C, Daoud Z, Hakimé NI, Hamzé M, Mangeney N, Matta H, Mokhbat JE, Rohban R, Sarkis DK, Doucet-Populaire F (2005) Countrywide spread of community- and hospital-acquired Extended Spectrum Beta Lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J Clin Microbiol 43: 3309-3313.
13. Matar GM, Al Khodor S, El-Zaatari M, Uwaydah M (2005) Prevalence of the genes encoding Extended Spectrum Beta Lactamases in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics. Ann Trop Med Parasit 99: 413-417.
14. Daoud Z, Hakime N (2003) Prevalence and susceptibility patterns of Extended Spectrum Beta Lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Rev Esp Quimioter 16: 233-238.
15. Clinical and Laboratory Standards Institute (2010) Methods for dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard- Eighth Edition 2010. CLSI document M07-A8: 26, no.2. Wayne, PA: CLSI.
16. Casin I, Breuil J, Brisabois A, Moury F, Grimont F, Collatz E (1999) Multidrug-resistant human and animal Salmonella typhimurium isolates in France belong predominantly to a DT104 clone with the chromosome- and integron-encoded beta-lactamase PSE-1. J Infect Dis 179: 1173-1182.
17. Mulvey MR, Soule G, Boyd D, Demczuk W, Ahmed R (2003) Characterization of the first extended-spectrum beta-lactamase-producing Salmonella isolate identified in Canada. J Clin Microbiol 41: 460-462.
18. Perilli M, Dell'Amico E, Segatore B, de Massis MR, Bianchi B, Luzzaro F, Rossolini GM, Toniolo A, Nicoletti G, Amicosante G (2002) Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 40:611-614.
19. Bouchakkour M, Zerouali K, Gros Claude JDP, Amarouch H, El Mdaghri N, Courvalin P, Timinouni M (2010) Plamsid mediated quinolone resistance in expanded spectrum beta lactamase producing Enterobacteriaceae in Morocco. J Infect Dev Ctries 4: 799-803.
20. Blondeau JM, Zhao X, Hansen G, Drlica K (2001) Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 45: 433-438.
21. Marcusson LL, Olofsson SK, Lindgren PK, Cars O, Hughes D (2005) Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli. J Antimicrob Chemother 55: 938-943.